Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy.
The postoperative course of six patients with primary hyperparathyroidism and obvious radiological evidence of bone disease pretreated with 1-alpha-hydroxy vitamin D3 (1 alpha HCC) was indistinguishable from that of six patients with a similar clinical and radiological picture who were not pretreated. 1alphaHCC may increase the hypercalcaemia in some cases and cannot be recommended for the routine preparation of such patients for surgery.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001847:Bone Diseases / Q000150:complications; D002118:Calcium / Q000097:blood; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000627:therapeutic use*; D006934:Hypercalcemia / Q000139:chemically induced; D006961:Hyperparathyroidism / Q000150:complications / Q000188:drug therapy*; D006996:Hypocalcemia / Q000517:prevention & control*; D008875:Middle Aged; D010280:Parathyroid Glands / Q000601:surgery; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D011300:Preoperative Care
D006887:Hydroxycholecalciferols; D002118:Calcium